登录 +0086-27-65522453 [email protected]

Acalisib 编号 : 16071413

化学信息

产品英文名称Acalisib
Iupac 化学名称(S)-2-(1-((7H-purin-6-yl)amino)ethyl)-6-fluoro-3-phenylquinazolin-4(3H)-one 
同义词GS-9820; GS9820 
英文同义词GS-9820; GS9820 
分子式C21H16FN7O 
分子量401.4 
SmileN1=CN=C2N=CNC2=C1N[[email protected]@H](C)C1=NC2=CC=C(C=C2C(N1C1=CC=CC=C1)=O)F
InChiKeyDOCINCLJNAXZQF-LBPRGKRZSA-N
InChiInChI=1S/C21H16FN7O/c1-12(27-19-17-18(24-10-23-17)25-11-26-19)20-28-16-8-7-13(22)9-15(16)21(30)29(20)14-5-3-2-4-6-14/h2-12H,1H3,(H2,23,24,25,26,27)/t12-/m0/s1
Cas870281-34-8

技术数据

外观Solid powder 
纯度98% by HPLC 
可溶性Soluble in DMSO 
存储-20 ºC for 3 years 
运输条件Shipped under ambient temperature 
质量控制

产品详情

Acalisib, also known as GS-9820, is an inhibitor of the beta and delta isoforms of the 110 kDa catalytic subunit of class IA phosphoinositide-3 kinases (PI3K) with potential immunomodulating and antineoplastic activities. p110beta/delta PI3K inhibitor GS-9820 inhibits the activity of PI3K, thereby preventing the production of the second messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3), which decreases tumor cell proliferation and induces cell death. PI3K-mediated signaling is often dysregulated in cancer cells; the targeted inhibition of PI3K is designed to preserve PI3K signaling in normal, non-neoplastic cells. Check for active clinical trials or closed clinical trials using this agent. 

结构

16071413 - Acalisib | CAS 870281-34-8

包装

规格价格
登录 to get price

快速订购

Change

联系我们